Ralph E. Howell

523 total citations
31 papers, 435 citations indexed

About

Ralph E. Howell is a scholar working on Molecular Biology, Physiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ralph E. Howell has authored 31 papers receiving a total of 435 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 16 papers in Physiology and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ralph E. Howell's work include Asthma and respiratory diseases (12 papers), Receptor Mechanisms and Signaling (9 papers) and Respiratory and Cough-Related Research (6 papers). Ralph E. Howell is often cited by papers focused on Asthma and respiratory diseases (12 papers), Receptor Mechanisms and Signaling (9 papers) and Respiratory and Cough-Related Research (6 papers). Ralph E. Howell collaborates with scholars based in United States. Ralph E. Howell's co-authors include Elliot M. Levine, Steven Μ. Albelda, D. E. Howell, B. Boyan-Salyers, C. N. Gillis, William J. Kinnier, Frederick R. Haselton, Stephen N. Mueller, A. P. Fishman and D S Grimes and has published in prestigious journals such as Journal of Applied Physiology, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Ralph E. Howell

31 papers receiving 402 citations

Peers

Ralph E. Howell
Kei Goto Japan
B Panczenko United States
Herman Ag Belgium
G. Allan United Kingdom
K. D. Voigt Germany
Ralph E. Howell
Citations per year, relative to Ralph E. Howell Ralph E. Howell (= 1×) peers Margherita Rosa

Countries citing papers authored by Ralph E. Howell

Since Specialization
Citations

This map shows the geographic impact of Ralph E. Howell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ralph E. Howell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ralph E. Howell more than expected).

Fields of papers citing papers by Ralph E. Howell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ralph E. Howell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ralph E. Howell. The network helps show where Ralph E. Howell may publish in the future.

Co-authorship network of co-authors of Ralph E. Howell

This figure shows the co-authorship network connecting the top 25 collaborators of Ralph E. Howell. A scholar is included among the top collaborators of Ralph E. Howell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ralph E. Howell. Ralph E. Howell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Howell, Ralph E., et al.. (1995). Pulmonary antiallergic and antiinflammatory effects of a novel, orallyactive phosphodiesterase IV inhibitor (WAY-127093B) in guinea pigs and rats. Inflammation Research. 44(S2). S172–S173. 5 indexed citations
2.
Howell, Ralph E., et al.. (1995). Inhibition of lipopolysaccharide-induced pulmonary edema by isozyme-selective phosphodiesterase inhibitors in guinea pigs.. Journal of Pharmacology and Experimental Therapeutics. 275(2). 703–709. 34 indexed citations
3.
Howell, Ralph E., et al.. (1995). Hypotensive effect of an M2‐selective muscarinic antagonist in anaesthetized guinea‐pigs. Journal of Autonomic Pharmacology. 15(1). 19–26. 4 indexed citations
4.
Howell, Ralph E., et al.. (1994). Pulmonary pharmacology of a novel, smooth muscle-selective muscarinic antagonist in vivo.. Journal of Pharmacology and Experimental Therapeutics. 270(2). 548–555. 8 indexed citations
5.
Howell, Ralph E., et al.. (1994). Leukotrienes mediate antigen-induced airway hyper-reactivity in guinea pigs.. Journal of Pharmacology and Experimental Therapeutics. 268(1). 353–358. 9 indexed citations
6.
Howell, Ralph E., et al.. (1994). Methoctramine induces nonspecific airway hyperresponsiveness in vivo. European Journal of Pharmacology. 265(1-2). 67–75. 1 indexed citations
7.
Glaser, Keith B., Richard P. Carlson, Anita Sung, et al.. (1993). Pharmacological characterization of WAY-121,520: A potent anti-inflammatory indomethacin-based inhibitor of 5-lipoxygenase (5-LO)/phospholipase A2 (PLA2). Inflammation Research. 39(S1). C30–C32. 6 indexed citations
8.
Howell, Ralph E., et al.. (1993). Pulmonary antiallergic and bronchodilator effects of isozyme-selective phosphodiesterase inhibitors in guinea pigs.. Journal of Pharmacology and Experimental Therapeutics. 264(2). 609–615. 52 indexed citations
9.
Howell, Ralph E., et al.. (1993). Potential Species Dependency for the Pulmonary Antiallergic Effects of Aerosolized Heparin. Pulmonary Pharmacology. 6(4). 237–239. 7 indexed citations
10.
Howell, Ralph E., et al.. (1992). Comparison of the airway hyperreactivity produced by single and multiple antigen exposures in sensitized guinea pigs. Inflammation Research. 37(3-4). 195–197. 2 indexed citations
11.
Howell, Ralph E. & Paul N. Lanken. (1992). Pulmonary accumulation of propranolol in vivo: sites and physiochemical mechanism.. Journal of Pharmacology and Experimental Therapeutics. 263(1). 130–135. 6 indexed citations
12.
Howell, Ralph E., et al.. (1991). Characterization of the airway smooth muscle muscarinic receptor in vivo. European Journal of Pharmacology. 197(1-2). 109–112. 10 indexed citations
13.
Howell, Ralph E., et al.. (1991). Airway smooth muscle selectivity of the muscarinic antagonist DAC 5945 in vivo. European Journal of Pharmacology. 196(3). 323–326. 4 indexed citations
14.
Howell, Ralph E., et al.. (1990). Mechanism for the emetic side effect of xanthine bronchodilators. Life Sciences. 46(8). 563–568. 27 indexed citations
15.
Howell, Ralph E., et al.. (1990). Angiotensin-converting enzyme kinetics in an endothelial cell column. American Journal of Physiology-Lung Cellular and Molecular Physiology. 258(4). L188–L194. 1 indexed citations
16.
Howell, Ralph E., Paul N. Lanken, John Hansen‐Flaschen, et al.. (1989). Pulmonary extraction of propranolol in normal and oxygen-toxic sheep.. Journal of Pharmacology and Experimental Therapeutics. 250(1). 93–99. 5 indexed citations
17.
Howell, Ralph E., John Hansen‐Flaschen, & Eric B. Wheeldon. (1988). Pulmonary Angiotensin-converting Enzyme Activity in the Oxygen-toxic Sheep. American Review of Respiratory Disease. 138(1). 160–166. 2 indexed citations
18.
Howell, Ralph E. & Gerald O. Carrier. (1986). Influence of Magnesium on Norepinephrine- and Histamine-Induced Contractions of Pulmonary Vascular Smooth Muscle. Pharmacology. 33(1). 27–33. 8 indexed citations
19.
Howell, Ralph E., et al.. (1984). Analysis of rabbit pulmonary angiotensin converting enzyme kinetics in vivo.. Journal of Pharmacology and Experimental Therapeutics. 228(1). 154–160. 12 indexed citations
20.
Cook, D. Ryan, Ralph E. Howell, & C. N. Gillis. (1982). Xanthine Oxidase-Induced Lung Injury Inhibits Removal of 5-Hydroxytryptamine from the Pulmonary Circulation. Anesthesia & Analgesia. 61(8). 666???670–666???670. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026